Long-Term Impact of Prosthesis-Patient Mismatch After Transcatheter Aortic Valve Replacement in Patients With Small

Itamar Loewenstein1, Bar Gitter1, Tamar Itach1

  • 1Cardiology Department, Tel Aviv Medical Center, Affiliated With the School of Medicine at Tel Aviv University, Tel Aviv, Israel.

Abstract

Insights

Prosthesis-patient mismatch (PPM) is common in transcatheter aortic valve replacement (TAVR) for small aortic annuli (SAA). Significant PPM increases long-term mortality, highlighting the need for careful valve selection in SAA TAVR patients.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Prosthetic Heart Valves

Background:

  • Prosthesis-patient mismatch (PPM) is a frequent complication after transcatheter aortic valve replacement (TAVR).
  • PPM is particularly concerning in patients with small aortic annuli (SAA), potentially leading to worse clinical outcomes.
  • Understanding PPM in SAA TAVR is crucial for optimizing patient management and improving long-term results.

Purpose of the Study:

  • To investigate the incidence, predictors, and long-term clinical impact of PPM in patients undergoing TAVR for SAA.
  • To compare the occurrence and consequences of PPM specifically within the SAA TAVR population.
  • To identify factors associated with PPM and its influence on mortality after SAA TAVR.

Main Methods:

  • Retrospective analysis of 631 consecutive patients with SAA (annulus area ≤ 430 mm²) undergoing transfemoral TAVR.
  • Significant PPM defined as moderate or greater, classified per Valve Academic Research Consortium (VARC)-3 criteria.
  • Inverse probability treatment weighting (IPTW) used to identify predictors of PPM and long-term mortality.

Main Results:

  • Significant PPM occurred in 23.3% of SAA TAVR patients.
  • Predictors of PPM included Bioprosthetic-Embolic Valve (BEV) implantation and larger body surface area (BSA).
  • Significant PPM was independently associated with higher 5-year mortality (HR 1.97) and moderate/above paravalvular leak.

Conclusions:

  • Significant PPM remains highly prevalent in the SAA TAVR population.
  • BEV implantation and larger BSA are associated with increased PPM risk, while larger annulus perimeter shows a protective effect.
  • Significant PPM is an independent predictor of long-term mortality following SAA TAVR.

Related Concept Videos

Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
405
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
929
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
522